Quality Indicators of Cervical Cytopathology Tests in the Public Service in Minas Gerais, Brazil

Tobias, Alessandra Hermógenes Gomes; Amaral, Rita Goreti; Diniz, Elói Martins; Carneiro, Cláudia Martins

doi:10.1055/s-0035-1571175

Cited by 5 publications

(1 citation statement)

References 20 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cross-sectional Brazilian studies highlighted the importance of the indicators of the laboratories internal quality control in identifying any nonconformity from the moment the specimens arrive at the laboratory until the release of the results (Araujo et al, 2015;Tobias et al, 2016). These indicators could be obtained from some tools provided by the Brazilian Ministry of Health (Brasil, 2008a;2008b;2017a;2017b) indirectly, where the managers have to perform manual work in order to calculate them.…”

Section: Discussionmentioning

confidence: 99%

AD-SISCOLO: a decision-support tool to aid the management of a cervical cancer screening program

et al. 2018

View full text Add to dashboard Cite

This paper aims to develop a data warehouse (AD-SISCOLO) in order to support the management of the cervical cancer screening program in the municipality of Rio de Janeiro/Brazil. As a part of the management process, the program managers of the municipality perform tedious manual work in order to calculate a series of performance indicators and then take decisions based on them. Methods: AD-SISCOLO was implemented using the Pentaho BI Suite Business Intelligence Platform and the MySQL database management system. The indicators to be calculated and visualized in the tool were based on the municipal data of the cytopathology and histopathology tests from January 2012 until December 2014, which was obtained from the Information System of Cervical Cancer (SISCOLO) after a record linkage process. The follow-up indicators were based on a simplified version of the Brazilian guidelines for the cervical cancer screening. Results: AD-SISCOLO allows the visualization of a set of test-based and follow-up indicators from different views and dimensions, which enable managers to monitor all the phases of the screening process and to identify the process' failures. Conclusions: Compared with the current available environments in Brazil, AD-SISCOLO is unique in its visualization of the follow-up indicators of groups of women, according to their test results and age. Thereby it provides presentation flexibility to suit the program manager's needs.

show abstract

Section: Discussionmentioning

confidence: 99%

AD-SISCOLO: a decision-support tool to aid the management of a cervical cancer screening program

et al. 2018

View full text Add to dashboard Cite

show abstract

Incidence of cervical cytological abnormalities following a negative smear result in an opportunistic screening scenario: A cohort study

Pinho-França

Chein

Thuler

2019

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

Organized, Population-based Cervical Cancer Screening Program: It Would Be a Good Time for Brazil Now

Derchain

Zeferino

2016

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

Rev Bras Ginecol Obstet 2016;38:161-163. Estimates indicate that around 16,000 new cases of cervical cancer were diagnosed in 2014 in Brazil. This cancer is the third most frequent in Brazil, the first in the North region, and the fifth in the South region of the country. 1 The Unified Health System (SUS), the public health care system of Brazil, has implemented several actions for qualifying cervical cancer screening, but there are challenges to be overcome, such as the large national territory and heterogeneous resources from every site. 2 Despite the efforts made by SUS, the current cervical cancer screening has shown many weaknesses. There is no doubt that regular screening of appropriate women for cervical cancer with the cytopathology test reduces mortality from cervical cancer. 3 However, appropriate policy and program organization remain essential to achieve a good balance between benefit and harm of any screening program. The knowledge of the potential of population-based cervical screening to reduce the burden of cervical cancer in the population is doubtless. However, as pointed out by Dillner et al, 4 this knowledge has not always been translated into effective national programs. To be effective, cervical cancer screening should be performed in an organized, population-based screening program with comprehensive quality assurance covering all steps in the screening process. An organized program should include quality assurance in monitoring cervical cancer screening performance. The European guidelines define such a performance through achieving: (1) an invitation coverage of at least 95% of the target women; (2) an examination coverage of at least 70% (85% is desirable); and (3) a participation rate of at least 70% (85% is desirable). 5 The current recommendations for the SUS establish the cytology-based cervical cancer screening, conducted with a three-year interval after two consecutive annual negative exams. The target population for cervical cancer screening comprised women aged 25 to 64 years, which represents around 55 million Brazilian women. 6 Although SUS is universal, 25% of all Brazilians have private health; therefore, 41 million women are dependent on the SUS as their health care provider. In the last decade, SUS conducted 9 to 11 million cytological exams per year. 7 If it maintains the recommended age group and three-year interval preconized, the SUS would be able to include 27 to 33 million women in the screening program, reaching almost 70-85% women as preconized for an organized population-based program for cervical cancer screening. 4 In their Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013, Costa et al 8 observed that the Pap test coverage rate in Brazil is below 70%. Data from the Ministry of Health from 2012 and 2013 showed that around 50% of the cytological tests in Brazil were conducted on an annual basis and only 10% within a three-year interval. Also, around 20% of the tests were conducted on women less than 25 years of age. 9 Rega...

show abstract

Quality Indicators of Cervical Cytopathology Tests in the Public Service in Minas Gerais, Brazil

Cited by 5 publications

References 20 publications

AD-SISCOLO: a decision-support tool to aid the management of a cervical cancer screening program

AD-SISCOLO: a decision-support tool to aid the management of a cervical cancer screening program

Incidence of cervical cytological abnormalities following a negative smear result in an opportunistic screening scenario: A cohort study

Organized, Population-based Cervical Cancer Screening Program: It Would Be a Good Time for Brazil Now

Contact Info

Product

Resources

About